日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:Pemivibart用于暴露前预防,Vilobelimab用于危重症,Abatacept或Infliximab用于重症或危重症。

Bhimraj, Adarsh; Falck-Ytter, Yngve; Baden, Lindsey R; Bedimo, Roger; Cawcutt, Kelly; Cheng, Vincent Chi-Chung; Chew, Kara W; Chiotos, Kathleen; Daar, Eric S; Dzierba, Amy L; Glidden, David V; Hardy, Erica J; Johnson, Steven; Kim, Arthur Y; Li, Jonathan Z; MacBrayne, Christine; Martin, Greg S; Nadig, Nandita; Nakamura, Mari M; Pearson, Jeffrey C; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Shumaker, Amy Hirsch; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Morgan, Rebecca L; Gandhi, Rajesh T

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:维洛贝利单抗

Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L; Kim, Arthur Y; Martin, Greg S; Pearson, Jeffrey C; Shumaker, Amy Hirsch; Baden, Lindsey R; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W; Daar, Eric S; Glidden, David V; Hardy, Erica J; Johnson, Steven; Li, Jonathan Z; MacBrayne, Christine; Nakamura, Mari M; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L; Gandhi, Rajesh T

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab

美国传染病学会2025年COVID-19治疗和管理临床实践指南更新:英夫利昔单抗

Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L; Kim, Arthur Y; Martin, Greg S; Pearson, Jeffrey C; Shumaker, Amy Hirsch; Baden, Lindsey R; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W; Daar, Eric S; Glidden, David V; Hardy, Erica J; Johnson, Steven; Li, Jonathan Z; MacBrayne, Christine; Nakamura, Mari M; Riley, Laura; Shafer, Robert W; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L; Gandhi, Rajesh T

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

分子风险标志物可确定唐氏综合征髓系白血病复发的风险,且该风险超出可测量的残留病灶范围。

Berman, Jason N; Verma, Anupam; Viola, Shelton; Alonzo, Todd A; Wang, Yi-Cheng; Brodersen, Lisa Eidenschink; Loken, Michael; Beckman, Amy; Hirsch, Betsy; Raimondi, Susana; Chisholm, Karen M; Ma, Xiaotu; Ries, Rhonda; Meshinchi, Soheil; Gamis, Alan; Schore, Reuven; Taub, Jeffrey W; Kolb, E Anders; Cooper, Todd; Hitzler, Johann

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

美国传染病学会关于COVID-19患者治疗和管理的指南(2022年9月)

Bhimraj, Adarsh; Morgan, Rebecca L; Shumaker, Amy Hirsch; Baden, Lindsey R; Cheng, Vincent Chi-Chung; Edwards, Kathryn M; Gallagher, Jason C; Gandhi, Rajesh T; Muller, William J; Nakamura, Mari M; O'Horo, John C; Shafer, Robert W; Shoham, Shmuel; Murad, M Hassan; Mustafa, Reem A; Sultan, Shahnaz; Falck-Ytter, Yngve

Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

更正:成人1型糖尿病的管理。美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)共识报告

Holt, Richard I G; DeVries, J Hans; Hess-Fischl, Amy; Hirsch, Irl B; Kirkman, M Sue; Klupa, Tomasz; Ludwig, Barbara; Nørgaard, Kirsten; Pettus, Jeremy; Renard, Eric; Skyler, Jay S; Snoek, Frank J; Weinstock, Ruth S; Peters, Anne L

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

从2019冠状病毒病(COVID-19)治疗中汲取的经验教训:来自美国传染病学会(IDSA)COVID-19治疗指南专家组的重要观点

Bhimraj, Adarsh; Morgan, Rebecca L; Shumaker, Amy Hirsch; Baden, Lindsey; Cheng, Vincent C; Edwards, Kathryn M; Gandhi, Rajesh T; Gallagher, Jason C; Muller, William J; O'Horo, John C; Shoham, Shmuel; Wollins, Dana Swartzberg; Falck-Ytter, Yngve

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

疫情期间的治疗紧急使用授权(EUA):一把双刃剑

Bhimraj, Adarsh; Morgan, Rebecca L; Shumaker, Amy Hirsch; Lavergne, Valery; Baden, Lindsey; Cheng, Vincent Chi-Chung; Edwards, Kathryn M; Gandhi, Rajesh T; Gallagher, Jason C; Muller, William J; O'Horo, John C; Shoham, Shmuel; Wollins, Dana Swartzberg; Falck-Ytter, Yngve

Pharmacologic Treatment and Management of Coronavirus Disease 2019

2019冠状病毒病的药物治疗和管理

Shumaker, Amy Hirsch; Bhimraj, Adarsh

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

成人1型糖尿病的管理:美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告

Holt, Richard I G; DeVries, J Hans; Hess-Fischl, Amy; Hirsch, Irl B; Kirkman, M Sue; Klupa, Tomasz; Ludwig, Barbara; Nørgaard, Kirsten; Pettus, Jeremy; Renard, Eric; Skyler, Jay S; Snoek, Frank J; Weinstock, Ruth S; Peters, Anne L